Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Divestments (2020 - 2023)

Agilon Health (AGL) has disclosed Divestments for 4 consecutive years, with $2.2 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Divestments changed N/A year-over-year to $2.2 million, compared with a TTM value of $2.2 million through Dec 2023, up 338.6%, and an annual FY2023 reading of $2.2 million, up 338.6% over the prior year.
  • Divestments was $2.2 million for Q4 2023 at Agilon Health, up from $500000.0 in the prior quarter.
  • Across five years, Divestments topped out at $24.4 million in Q4 2020 and bottomed at -$3.7 million in Q1 2021.
  • Average Divestments over 4 years is $4.3 million, with a median of $1.2 million recorded in 2021.
  • The sharpest move saw Divestments crashed 94.67% in 2021, then surged 113.49% in 2022.
  • Year by year, Divestments stood at $24.4 million in 2020, then plummeted by 94.67% to $1.3 million in 2021, then crashed by 61.54% to $500000.0 in 2022, then surged by 338.6% to $2.2 million in 2023.
  • Business Quant data shows Divestments for AGL at $2.2 million in Q4 2023, $500000.0 in Q1 2022, and $1.3 million in Q4 2021.